Leprosy of the Past and Today

 

 Artikel einzeln kaufen Lizenzen und Reprints

Despite enhanced disease control efforts, leprosy remains an important cause of disability in several countries. Being based on case detection, the exact prevalence of the disease is not easily estimated. Currently around 600,000 new cases are treated annually. Advances in immunology and molecular biology have led to a greater understanding of the disease and to hopes for improved diagnostic tests and vaccination strategies. The major advance, though, is the development of highly effective combination drug regimens which, provided all doses are taken, rarely fails to cure. The challenge to leprosy control services is to overcome the stigma associated with the disease so that patients present with minimal lesions and before disabilities have developed. Although it is hoped that leprosy as a serious public health problem will be eliminated within a few years, continuing care for those suffering from deformity and rejection by society will be required for several decades.

REFERENCES

• 1 Grange J M. Lupus and lepros.  Int J Lepr Other Mycobact Dis. 1988;  56 111-112
  MissingFormLabel

  PubMedSuche in Google Scholar
• 2 Robertson J O. International Leprosy Association global project on the history of leprosy. Editorial.  Lepr Rev. 2003;  74 103-111
  MissingFormLabel

  PubMedSuche in Google Scholar
• 3 World Health Organization .Global Strategy for the Elimination of Leprosy as a Public Health Problem. Geneva; World Health Organization 1999
  MissingFormLabel

  Suche in Google Scholar
• 4 World Health Organization .Chemotherapy of Leprosy for Control Programmes. Report of a WHO Study Group, TRS 675. Geneva; World Health Organization 1982
  MissingFormLabel

  Suche in Google Scholar
• 5 Cole S T, Eiglmeier K, Parkhill J et al.. Massive gene decay in the leprosy bacillus.  Nature. 2001;  409 1007-1011
  MissingFormLabel

  CrossrefPubMedSuche in Google Scholar
• 6 Young D, Robertson B. Genomics: leprosy: a degenerative disease of the genome.  Curr Biol. 2001;  11 R381-R383
  MissingFormLabel

  CrossrefPubMedSuche in Google Scholar
• 7 Brennan P J, Vissa V D. Genomic evidence for the retention of the essential mycobacterial cell wall in the otherwise defective Mycobacterium leprae .  Lepr Rev. 2001;  72 415-428
  MissingFormLabel

  PubMedSuche in Google Scholar
• 8 Sassetti C M, Boyd D H, Rubin E J. Genes required for mycobacterial growth defined by high density mutagenesis.  Mol Microbiol. 2003;  48 77-84
  MissingFormLabel

  CrossrefPubMedSuche in Google Scholar
• 9 Stanford J L, Rook G AW, Convit J et al.. Preliminary taxonomic studies on the leprosy bacillus.  Br J Exp Pathol. 1975;  56 579-585
  MissingFormLabel

  PubMedSuche in Google Scholar
• 10 Chakrabarty A N, Dastidar S G. Is soil an alternative source of leprosy infection?.  Acta Leprol. 2001-2002;  12 79-84
  MissingFormLabel

  PubMedSuche in Google Scholar
• 11 Grange J M, Dewar C A, Rowbotham T J. Microbe-dependence of Mycobacterium leprae: a possible intracellular relationship with protozoa.  Int J Lepr Other Mycobact Dis. 1987;  55 565
  MissingFormLabel

  PubMedSuche in Google Scholar
• 12 Kazda J, Irgens L M, Muller K. Isolation of noncultivable acid-fast bacilli in sphagnum moss vegetation by footpad technique in mice.  Int J Lepr Other Mycobact Dis. 1980;  48 1-6
  MissingFormLabel

  PubMedSuche in Google Scholar
• 13 Mendum T A, Chilima B Z, Hirsch P R. The PCR amplification of nontuberculous mycobacterial 16S rRNA sequences from soil.  FEMS Microbiol Lett. 2000;  185 189-192
  MissingFormLabel

  CrossrefPubMedSuche in Google Scholar
• 14 Valverde C R, Canfield D, Tarara R, Esteves M I, Gormus B J. Spontaneous leprosy in a wild-caught cynomolgus macaque.  Int J Lepr Other Mycobact Dis. 1998;  66 140-148
  MissingFormLabel

  PubMedSuche in Google Scholar
• 15 Paige C F, Scholl D T, Truman R W. Prevalence and incidence density of Mycobacterium leprae and Trypanosoma cruzi infections within a population of wild nine-banded armadillos.  Am J Trop Med Hyg. 2002;  67 528-532
  MissingFormLabel

  PubMedSuche in Google Scholar
• 16 Lumpkin L R, Cox G F, Wolf J E. Leprosy in five armadillo handlers.  J Am Acad Dermatol. 1983;  9 899-903
  MissingFormLabel

  PubMedSuche in Google Scholar
• 17 Davey T F, Rees R JW. The nasal discharge in leprosy: clinical and bacteriological aspects.  Lepr Rev. 1974;  45 121-134
  MissingFormLabel

  PubMedSuche in Google Scholar
• 18 Sehgal V N. Leprosy following mechanical trauma.  Lepr Rev. 1986;  57 74-76
  MissingFormLabel

  PubMedSuche in Google Scholar
• 19 Blake L A, West B C, Lary C H, Todd IV J R. Environmental nonhuman sources of leprosy.  Rev Infect Dis. 1987;  9 562-577
  MissingFormLabel

  PubMedSuche in Google Scholar
• 20 World Health Organization . Leprosy: global situation.  Wkly Epidemiol Rec. 2000;  75 226-231
  MissingFormLabel

  PubMedSuche in Google Scholar
• 21 World Health Organization .Leprosy. Fact Sheet No. 101. Revised January 2003 Geneva; World Health Organization 2003
  MissingFormLabel

  Suche in Google Scholar
• 22 Leprosy Group, WHO .Leprosy. In: Cook GC, Zumla A Manson's Tropical Diseases. 21st ed. Edinburgh; Saunders (Elsevier) 2003: 1065-1084
  MissingFormLabel

  Suche in Google Scholar
• 23 Lockwood D NJ. Leprosy (Hansen's disease). In: Warrell DA, Cox TM, Firth JD, Benz EJ Oxford Textbook of Medicine. 4th ed. Oxford; Oxford University Press 2003: 575-584
  MissingFormLabel

  Suche in Google Scholar
• 24 Narayan N P, Ramu G, Desikan K V, Vallishayee R S. Correlation of clinical, histological and immunological features across the leprosy spectrum.  Indian J Lepr. 2001;  73 329-342
  MissingFormLabel

  PubMedSuche in Google Scholar
• 25 Brennan P J. Skin test development in leprosy: progress with first-generation skin test antigens, and an approach to the second generation.  Lepr Rev. 2000;  71(suppl) S50-S54
  MissingFormLabel

  PubMedSuche in Google Scholar
• 26 Torres P, Camarena J J, Gomez J R et al.. Comparison of PCR mediated amplification of DNA and the classical methods for detection of Mycobacterium leprae in different types of clinical samples in leprosy patients and contacts.  Lepr Rev. 2003;  74 18-30
  MissingFormLabel

  PubMedSuche in Google Scholar
• 27 Kang T J, Kim S K, Lee S B, Chae G T, Kim J P. Comparison of two different PCR amplification products (the 18-kDa protein gene vs. RLEP repetitive sequence) in the diagnosis of Mycobacterium leprae .  Clin Exp Dermatol. 2003;  28 420-424
  MissingFormLabel

  CrossrefPubMedSuche in Google Scholar
• 28 Chae G T, Kim M J, Kang T J et al.. DNA-PCR and RT-PCR for the 18-kDa gene of Mycobacterium leprae to assess the efficacy of multi-drug therapy for leprosy.  J Med Microbiol. 2002;  51 417-422
  MissingFormLabel

  PubMedSuche in Google Scholar
• 29 Ridley D S, Jopling W H. Classification of leprosy according to immunity: a five-group system.  Int J Lepr Other Mycobact Dis. 1966;  34 255-273
  MissingFormLabel

  PubMedSuche in Google Scholar
• 30 Godal M B, Myrvang B, Stanford J L, Samuel D R. Recent advances in the immunology of leprosy with special reference to new approaches in immunoprophylaxis.  Bull Inst Pasteur. 1974;  72 273-310
  MissingFormLabel

  PubMedSuche in Google Scholar
• 31 Waters M F, Stanford J L. Giant reactions to tuberculin in lepromatous leprosy patients.  Int J Lepr Other Mycobact Dis. 1985;  53 546-553
  MissingFormLabel

  PubMedSuche in Google Scholar
• 32 Sampaio E P, Duppre N C, Nery J A, Moreira A L, Sarno E N. Development of giant reaction in response to PPD skin test in lepromatous leprosy patients.  Int J Lepr Other Mycobact Dis. 1993;  61 205-213
  MissingFormLabel

  PubMedSuche in Google Scholar
• 33 Bloom B R, Salgame P, Diamond B. Revisiting and revising suppressor T cells.  Immunol Today. 1992;  13 131-136
  MissingFormLabel

  CrossrefPubMedSuche in Google Scholar
• 34 Hashimoto K, Maeda Y, Kimura H et al.. Mycobacterium leprae infection in monocyte-derived dendritic cells and its influence on antigen-presenting function.  Infect Immun. 2002;  70 5167-5176
  MissingFormLabel

  CrossrefPubMedSuche in Google Scholar
• 35 Bloom B R. Learning from leprosy: a perspective on immunology and the third world (American Association of Immunologists Presidential Address).  J Immunol. 1986;  137 i-x
  MissingFormLabel

  PubMedSuche in Google Scholar
• 36 Modlin R L, Hofman F M, Taylor C R, Rea T H. T-lymphocyte subsets in the skin lesions of patients with leprosy.  J Am Acad Dermatol. 1983;  8 182-189
  MissingFormLabel

  PubMedSuche in Google Scholar
• 37 Yamamura M, Uyemura K, Deans R J et al.. Defining protective responses to pathogens: cytokine profiles in leprosy patients.  Science. 1991;  254 277-279
  MissingFormLabel

  PubMedSuche in Google Scholar
• 38 Rook G AW, Zumla A. Advances in the immunopathogenesis of pulmonary tuberculosis.  Curr Opin Pulm Med. 2001;  7 116-123
  MissingFormLabel

  CrossrefPubMedSuche in Google Scholar
• 39 Stanford J L, Stanford C A, Grange J M. Environmental echoes.  Sci Prog. 2001;  84(pt 2) 105-124
  MissingFormLabel

  PubMedSuche in Google Scholar
• 40 Muzur A, Skrobonja A, Rotschild V, Skrobonja Jr A. Saints protectors from leprosy: historical hints of suggestive therapy?.  Int J Lepr Other Mycobact Dis. 2002;  70 269-273
  MissingFormLabel

  PubMedSuche in Google Scholar
• 41 Stanford J L. The history and future of vaccination and immunotherapy for leprosy.  Trop Geogr Med. 1994;  46 93-107
  MissingFormLabel

  PubMedSuche in Google Scholar
• 42 Samuel N M, Grange J M, Samuel S et al.. A study of the effects of intradermal administration of recombinant gamma interferon in lepromatous leprosy patients.  Lepr Rev. 1987;  58 389-400
  MissingFormLabel

  PubMedSuche in Google Scholar
• 43 Nath I, Vemuri N, Reddi A L et al.. The effect of antigen presenting cells on the cytokine profiles of stable and reactional lepromatous leprosy patients.  Immunol Lett. 2000;  75 69-76
  MissingFormLabel

  CrossrefPubMedSuche in Google Scholar
• 44 Filley E, Andreoli A, Steele J et al.. A transient rise in agalactosyl IgG correlating with free interleukin-2 receptors during episodes of erythema nodosum leprosum.  Clin Exp Immunol. 1989;  76 343-347
  MissingFormLabel

  PubMedSuche in Google Scholar
• 45 Spierings E, de Boer T, Wieles B et al.. Mycobacterium leprae-specific, HLA Class II-restricted killing of human schwann cells by CD4+ Th1 cells: a novel immunopathogenic mechanism of nerve damage in leprosy.  J Immunol. 2001;  166 5883-5888
  MissingFormLabel

  PubMedSuche in Google Scholar
• 46 Oliveira R B, Ochoa M T, Sieling P A et al.. Expression of Toll-like receptor 2 on human Schwann cells: a mechanism of nerve damage in leprosy.  Infect Immun. 2003;  71 1427-1433
  MissingFormLabel

  CrossrefPubMedSuche in Google Scholar
• 47 Kang T J, Chae G T. Detection of Toll-like receptor 2 (TLR2) mutation in the lepromatous leprosy patients.  FEMS Immunol Med Microbiol. 2001;  31 53-58
  MissingFormLabel

  CrossrefPubMedSuche in Google Scholar
• 48 Abbot N C, Beck J S, Samson P D, Butlin C R, Bennett P J, Grange J M. Cold fingers in leprosy.  Int J Lepr Other Mycobact Dis. 1992;  60 580-586
  MissingFormLabel

  PubMedSuche in Google Scholar
• 49 Abbot N C, Beck J S, Samson P D et al.. Impairment of fingertip vasomotor reflexes in leprosy patients and apparently healthy contacts.  Int J Lepr Other Mycobact Dis. 1991;  59 537-547
  MissingFormLabel

  PubMedSuche in Google Scholar
• 50 Abbot N C, Beck J S, Feval F et al.. Immunotherapy with Mycobacterium vaccae and peripheral blood flow in long-treated leprosy patients, a randomised, placebo-controlled trial.  Eur J Vasc Endovasc Surg. 2002;  24 202-208
  MissingFormLabel

  CrossrefPubMedSuche in Google Scholar
• 51 Courtright P, Daniel E, Sundarrao et al.. Eye disease in multibacillary leprosy patients at the time of their leprosy diagnosis: findings from the Longitudinal Study of Ocular Leprosy (LOSOL) in India, the Philippines and Ethiopia.  Lepr Rev. 2002;  73 225-238
  MissingFormLabel

  PubMedSuche in Google Scholar
• 52 Ridley D S. Pathogenesis of Leprosy and Related Diseases. London; Wright 1988: 89
  MissingFormLabel

  Suche in Google Scholar
• 53 Nakayama E E, Ura S, Fleury R N, Soares V. Renal lesions in leprosy: a retrospective study of 199 autopsies.  Am J Kidney Dis. 2001;  38 26-30
  MissingFormLabel

  PubMedSuche in Google Scholar
• 54 Eastwood J B, Dilley S A, Grange J M. Tuberculosis, leprosy and other mycobacterial diseases. In: Cattel W Infections of the Kidney and Urinary Tract. Oxford; Oxford University Press 1996: 291-318
  MissingFormLabel

  Suche in Google Scholar
• 55 Saporta L, Yuksel A. Androgenic status in patients with lepromatous leprosy.  Br J Urol. 1994;  74 221-224
  MissingFormLabel

  PubMedSuche in Google Scholar
• 56 Ishikawa S, Mizushima M, Furuta M, Ishikawa A, Kawamura K. Leydig cell hyperplasia and the maintenance of bone volume: bone histomorphometry and testicular histopathology in 29 male leprosy autopsy cases.  Int J Lepr Other Mycobact Dis. 2000;  68 258-266
  MissingFormLabel

  PubMedSuche in Google Scholar
• 57 Neena K, Ammini A C, Singh M, Pandhi R K. Ovarian function in female patients with multibacillary leprosy.  Int J Lepr Other Mycobact Dis. 2003;  71 101-105
  MissingFormLabel

  CrossrefPubMedSuche in Google Scholar
• 58 Lienhardt C, Kamate B, Jamet P et al.. Effect of HIV infection on leprosy: a three-year survey in Bamako, Mali.  Int J Lepr Other Mycobact Dis. 1996;  64 383-391
  MissingFormLabel

  PubMedSuche in Google Scholar
• 59 Lucas S. Human immunodeficiency virus and leprosy.  Lepr Rev. 1993;  64 97-103
  MissingFormLabel

  PubMedSuche in Google Scholar
• 60 Lawn S D, Wood C, Lockwood D N. Borderline tuberculoid leprosy: an immune reconstitution phenomenon in a human immunodeficiency virus-infected person.  Clin Infect Dis. 2003;  36 e5-e6
  MissingFormLabel

  CrossrefPubMedSuche in Google Scholar
• 61 Brown J AK, Stone M M, Sutherland I. BCG vaccination of children against leprosy in Uganda: first results.  BMJ. 1966;  1 7-14
  MissingFormLabel

  PubMedSuche in Google Scholar
• 62 Gupte M D. Vaccine trials in leprosy: Venezuela, Malawi and India.  Int J Lepr Other Mycobact Dis. 1999;  67(suppl 4) S32-S37
  MissingFormLabel

  PubMedSuche in Google Scholar
• 63 Gupte M D, Vallishayee R S, Anantharaman D S et al.. Comparative leprosy vaccine trial in south India.  Indian J Lepr. 1998;  70 369-388
  MissingFormLabel

  PubMedSuche in Google Scholar
• 64 Azuly R D. Antileprosy vaccinations.  An Bras Dermatol. 2002;  77 489-494
  MissingFormLabel

  PubMedSuche in Google Scholar
• 65 Ramu G, Grange J M, Stanford J L. Evaluation of adjunct immunotherapy with killed Mycobacterium vaccae in the treatment of multibacillary leprosy and erythema nodosum leprosum. In: Casal M Clinical Mycobacteriology. Barcelona; Prous Science 1998: 393-402
  MissingFormLabel

  Suche in Google Scholar
• 66 World Health Organization .Expert Committee on Leprosy. WHO Technical Report series, No. 874. Geneva; World Health Organization 1998
  MissingFormLabel

  Suche in Google Scholar
• 67 World Health Organization .7th WHO Expert Committee on leprosy June 1997. Geneva; World Health Organization 1997
  MissingFormLabel

  Suche in Google Scholar
• 68 Lockwood D, Marlowe S. Leprosy. In: Finch RG, Greenwood D, Norrby SR, Whitley RJ Antibiotic and Chemotherapy. 8th ed. Edinburgh; Churchill Livingstone 2003: 808-816
  MissingFormLabel

  Suche in Google Scholar
• 69 Withington S G, Joha S, Baird D, Brink M, Brink J. Assessing socioeconomic factors in relation to stigmatisation, impairment status, and selection for socioeconomic rehabilitation: a 1-year cohort of new leprosy cases in north Bangladesh.  Lepr Rev. 2003;  74 120-123
  MissingFormLabel

  PubMedSuche in Google Scholar
• 70 de Stigter D H, de Geus L, Heynders M L. Leprosy: between acceptance and segregation: community behavior towards persons affected by leprosy in eastern Nepal.  Lepr Rev. 200;  71 492-498
  MissingFormLabel

  PubMedSuche in Google Scholar
• 71 Rao S, Garole V, Walawalkar S et al.. Gender differences in the social impact of leprosy.  Lepr Rev. 1996;  67 190-199
  MissingFormLabel

  PubMedSuche in Google Scholar
• 72 Peters E S, Eshiet A L. Male-female (sex) differences in leprosy patients in south eastern Nigeria: females present late for diagnosis and treatment and have higher rates of deformity.  Lepr Rev. 2002;  73 262-267
  MissingFormLabel

  PubMedSuche in Google Scholar
• 73 Arole S, Premkumar R, Arole R, Maury M, Saunderson P. Social stigma: a comparative qualitative study of integrated and vertical care approaches to leprosy.  Lepr Rev. 2002;  73 186-196
  MissingFormLabel

  PubMedSuche in Google Scholar
• 74 Van Dijk M, Visschedijk J, Van Der Kwaak A. “Client satisfaction”: guidelines for assessing the quality of leprosy services from the clients' perspective.  Lepr Rev. 2003;  74 112-119
  MissingFormLabel

  PubMedSuche in Google Scholar
• 75 Reichman L B. The U-shaped curve of concern.  Am Rev Respir Dis. 1991;  144 741-742
  MissingFormLabel

  PubMedSuche in Google Scholar

John M GrangeM.Sc. M.D. 

Centre for Infectious Diseases and International Health, Royal Free and University College Medical School, Windeyer Institute for Medical Sciences

46 Cleveland Street, London, W1T 4JF, UK

eMail: sophia@hagia.freserve.co.uk